Drug Pricing Plan Fails Key Test Of Democratic Support
With three moderate Democrats joining Republican opposition, the drug pricing provision was not approved in the House Energy and Commerce Committee’s markup. Though the measure to allow Medicare to broadly negotiate prescription prices later passed another committee, the day's events heightened concerns over whether it can pass the full House.